Ptc Therapeutics PTCT
NASDAQ PTCT
$69.73 -1.67 (-2.34%)
As of: Sep 4, 2026 · 2:27 PM EDT

Ptc Therapeutics (PTCT) Gross Margin (QoQ) (2016 - 2026)

Analysis

Ptc Therapeutics (PTCT) Gross Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Ptc Therapeutics 5.79 Bn 3.56 Bn 340.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 476.00
Mar 31, 2026 -606.00
Dec 31, 2025 326.00
Sep 30, 2025 -109.00
Jun 30, 2025 -529.00
Mar 31, 2025 654.00
Dec 31, 2024 -213.00
Sep 30, 2024 280.00
Jun 30, 2024 -130.00
Mar 31, 2024 247.00
Dec 31, 2023 -465.00
Sep 30, 2023 113.00
Jun 30, 2023 46.00
Mar 31, 2023 9.00
Dec 31, 2022 -5.00
Sep 30, 2022 -63.00
Jun 30, 2022 99.00
Mar 31, 2022 -117.00
Dec 31, 2021 -93.00
Sep 30, 2021 159.00